Theragnostics inks AstraZeneca agreement

AuntMinnie.com staff writers
Sep 4, 2019

Molecular radiotherapy developer Theragnostics said it has signed an intellectual property agreement with AstraZeneca.

The agreement allows Theragnostics to develop radiotherapy based on radionuclide-labeled poly (ADP-ribose) polymerase (PARP) inhibitors, a class of oncology drugs that block the PARP enzyme, which cancer cells use in response to DNA damage.
Latest in Radiation Oncology/Therapy
Acquisitions
Telix and Varian enter research collaboration
December 10, 2025
Ge Hc Logo 400
GE HealthCare inks RT, AI partnerships
December 5, 2025
Astro
ASTRO issues guidance on radiation therapy for stomach cancer
November 19, 2025
Radiation Therapy Planning 400 (1)
Partial breast irradiation effective in women with HR+ cancers
November 14, 2025
Related Stories
2021 09 14 23 49 7847 Business Handshake 400
Molecular Imaging
Theragnostics enters licensing deal with AAA for Ga-68 PET
2020 07 28 23 23 5650 Business Hands Cooperation 400
Molecular Imaging
Theragnostics names two new board directors
2017 09 14 23 05 1167 Cancer Cell 400
Molecular Imaging
Theragnostics, German hospital to study THG-008 for PET
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
AI
AstraZeneca, Qure.ai partner for lung cancer diagnosis
More in Radiation Oncology/Therapy
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
GE HealthCare inks RT, AI partnerships
By AuntMinnie.com staff writers
GE HealthCare announced two key collaborations for its existing and new imaging technology at RSNA 2025.
December 5, 2025
Ge Hc Logo 400
ASTRO issues guidance on radiation therapy for stomach cancer
By AuntMinnie.com staff writers
The recommendations are based on a systematic review of research published from 2001 through mid-2025.
November 19, 2025
Astro
Partial breast irradiation effective in women with HR+ cancers
By Amerigo Allegretto
Stereotactic partial breast irradiation can lead to higher rates of pathological complete response in women with HR+ cancers.
November 14, 2025
Radiation Therapy Planning 400 (1)
GT Medical releases interim data for GammaTile trial
By AuntMinnie.com staff writers
The interim findings showed superior efficacy for GammaTile with a safety profile comparable to the standard of care.
October 21, 2025
Brain Abstract 400
Pluvicto reduces progression of advanced prostate cancer
By AuntMinnie.com staff writers
New study findings were presented October 19 at the European Society for Medical Oncology 2025 annual meeting in Berlin.
October 20, 2025
Prostate Imaging
Accuray taps new CEO
By AuntMinnie.com staff writers
Steve La Neve brings more than 40 years of international medical technology experience to his new position.
October 20, 2025
Accuray Astro 2019
Could more imaging access improve prison cancer care?
By Amerigo Allegretto
One potential strategy for improving cancer care among incarcerated individuals is more access to screening tests.
October 15, 2025
Doctors Working Monitor Consult 400
Elekta releases report on radiotherapy's role in cancer care
By AuntMinnie.com staff writers
Elekta called for broader adoption, proper reimbursement, and global access to radiotherapy in cancer care in a new report.
October 9, 2025
Radiation Therapy Suite 400
PSMA PET-guided radiotherapy shows promise
By Will Morton
A trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.
October 3, 2025
Prostate Imaging
Accuray partners with UW-Madison
By AuntMinnie.com staff writers
The first helical radiation delivery platform, the TomoTherapy system, was invented by UW-Madison researchers.
October 1, 2025
Accuray
ASTRO: Short prostate SBRT reduces side effects, but not PSA levels
By Kate Madden Yee
Study findings offer new evidence to help guide treatment decisions for patients with localized prostate cancer, researchers said.
October 1, 2025
Astro Sf
Page 1 of 467
Next Page